Literature DB >> 9054502

The MHC reactivity of the T cell repertoire prior to positive and negative selection.

J Zerrahn1, W Held, D H Raulet.   

Abstract

T cell antigen receptors (TCRs) on mature T cells react with peptide antigens presented by self-MHC proteins and also frequently cross-react with foreign MHC proteins. The fundamental question whether MHC reactivity is inherent in the germline TCR sequences or is imposed by thymic selection was addressed here by inducing nonselective maturation of immature thymocytes in the absence of MHC molecules. MHC reactivity in the preselection repertoire is very high, but no higher than in the normal repertoire. Cross-reactivity of clones with multiple MHC molecules occurred to a similar extent in the preselection and MHC-selected repertoires. The results establish the MHC reactivity of the germline TCR repertoire, indicate the minimum fraction of immature thymocytes that must undergo negative selection, and suggest that some TCR-MHC contacts may be conserved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054502     DOI: 10.1016/s0092-8674(00)81905-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  94 in total

1.  Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor.

Authors:  B K Cho; K C Lian; P Lee; A Brunmark; C McKinley; J Chen; D M Kranz; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.

Authors:  Olivier Joffre; Nathalie Gorsse; Paola Romagnoli; Denis Hudrisier; Joost P M van Meerwijk
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

3.  Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability.

Authors:  Scott R Burrows; Zhenjun Chen; Julia K Archbold; Fleur E Tynan; Travis Beddoe; Lars Kjer-Nielsen; John J Miles; Rajiv Khanna; Denis J Moss; Yu Chih Liu; Stephanie Gras; Lyudmila Kostenko; Rebekah M Brennan; Craig S Clements; Andrew G Brooks; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-18       Impact factor: 11.205

4.  Evolving concepts of specificity in immune reactions.

Authors:  Herman N Eisen; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

5.  MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection.

Authors:  François Van Laethem; Anastasia N Tikhonova; Alfred Singer
Journal:  Trends Immunol       Date:  2012-07-06       Impact factor: 16.687

6.  Reconciling views on T cell receptor germline bias for MHC.

Authors:  K Christopher Garcia
Journal:  Trends Immunol       Date:  2012-07-06       Impact factor: 16.687

7.  How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire.

Authors:  Sydney J Blevins; Brian G Pierce; Nishant K Singh; Timothy P Riley; Yuan Wang; Timothy T Spear; Michael I Nishimura; Zhiping Weng; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

8.  Functional evidence for TCR-intrinsic specificity for MHCII.

Authors:  Heather L Parrish; Neha R Deshpande; Jelena Vasic; Michael S Kuhns
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

9.  T cell receptor interactions with class I heavy-chain influence T cell selection.

Authors:  S T Kuhns; M D Tallquist; A J Johnson; Y Mendez-Fernandez; L R Pease
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

10.  Effect of CDR3 sequences and distal V gene residues in regulating TCR-MHC contacts and ligand specificity.

Authors:  Brian D Stadinski; Peter Trenh; Brian Duke; Priya G Huseby; Guoqi Li; Lawrence J Stern; Eric S Huseby
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.